Prior to joining the University of South Alabama as Assistant Vice President, Research Innovation, Dr. Chambers founded and served as President and CEO of Swift Biotech, a company developing technologies to fight cancer.  Before Swift, Chambers helped found and served as CEO of InnoRx Pharmaceuticals, an ocular drug delivery company.  He negotiated its sale to SurModics (NASDAQ: SRDX) in 2005.

Prior Chairman of ProUroCare, a public company based in Minneapolis, he has served on the boards of InQ Biosystems, Gene Capture, BioAlabama and the EDPA.  He was a co-author of the Commercialization portion of theAlabama Science & Technology Roadmap commissioned by then Governor Bob Riley.

Dr. Chambers has been recognized in Best Attorneys in the United States in Commercial Law, Arbitration and Mediation, and recognized as a Top Attorney in Health Care. 

Past Affiliations

Adjunct Professor for Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama
2015 - Present

PhD, Université des Hautes Etudes Internationales, Université de Genève, Switzerland, Economics, 1996
Certificate, Université de Lille, Law, 1979
J.D., University of Alabama, Law, 1979
B.A., University of Alabama, 1975
innovation economic development entrepreneurship

District Governor of Rotary, Rotary, 2015

Start-Up Executive of the Year, 2014, Alabama LaunchPad, EDPA Alabama LaunchPad, 2014

Service Above Self Award, Rotary International, 2014

Chairman, Mobile Area Chamber of Commerce, 2014

Citation of Meritorious Service, The Rotary Foundation, 2012

Swiss Confederation Fellowship, Swiss Confederation, 1980-1982

Rotary Ambassadorial Scholar, Rotary International, 1979

Board of Directors: EDPA, Gene Capture, InQBio, ProUroCare, Goodwill Easter Seal, Rotary Childrens' Foundation, Mobile Area Chamber of Commerce, Prichard Preparatory School and 1702.